Showing results (981-990 of 11,582) with videos related to
Sort By:
Pageof 1,159
International Journal of Oncology|June 22, 1999
Tumor necrosis factor and gamma-interferon repress transcription from the c-myc P2 promoter by reducing E2F binding activityA L Carlberg, K H Moberg, D J HallInternational Journal of Oncology|June 22, 1999
Involvement of galectin-3 expression in colorectal cancer progression and metastasisM Nakamura, H Inufusa, T Adachi, et al.International Journal of Oncology|June 22, 1999
A comparison of the modulation of antiblastics cytotoxicity by verapamil and dipyridamole in a human colon carcinoma cell lineE Berti, M Carrara, E Ragazzi, et al.International Journal of Oncology|June 22, 1999
Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one centerG Tomer, I J Cohen, D Kidron, et al.International Journal of Oncology|October 28, 1999
Prospective long-term endoscopic and histologic follow-up of gastric lymphoproliferative disease of early stage IE low-grade B-cell mucosa-associated lymphoid tissue type following Helicobacter pylori eradication treatmentA P Weston, S K Banerjee, R T Horvat, et al.International Journal of Oncology|October 28, 1999
Telomerase activity in non-small cell lung carcinomas correlates with smoking statusG Xinarianos, F M Scott, T Liloglou, et al.International Journal of Oncology|October 28, 1999
Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphomaP C Chinn, J E Leonard, J Rosenberg, et al.International Journal of Oncology|November 24, 1999
Decreased expression of telomerase-associated RNAs in the proliferation of stem cells in comparison with continuous expression in malignant tumorsM Sugihara, K Ohshima, H Nakamura, et al.International Journal of Oncology|November 24, 1999
A significant morphological transformation is recognized in human esophageal cancer cells with an amplification/overexpression of the cyclin D1 geneM Watanabe, H Kuwano, S Tanaka, et al.International Journal of Oncology|November 24, 1999
Prognostic benefit in cytoreductive surgery for curatively unresectable hepatocellular carcinoma - comparison to transcatheter arterial chemoembolizationJ Nagashima, K Okuda, M Tanaka, et al.Pageof 1,159